Novartis
Search results
- Open35.72High35.88Low35.65
- Mkt Cap15.43BP/E (TTM)N/ADiv & Yield0.45 & 1.26%
- Prev. Close35.8552 Wk. Low22.7052 Wk. High38.52
Related stocks
Open | 35.72 |
High | 35.88 |
Low | 35.65 |
Mkt Cap | 15.43B |
P/E (TTM) | N/A |
Div & Yield | 0.45 & 1.26% |
Prev. Close | 35.85 |
52 Wk. Low | 22.70 |
52 Wk. High | 38.52 |
Related stocks
Pharmaceutical company
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 2.53B | 2.70% ▲ |
Net Income | 75M | 36.20% ▼ |
Diluted EPS | 36.20% ▼ |
S&P FuturesES=F | 5,452.50+33.00 (+0.61%) |
Dow FuturesYM=F | 40,591.00+184.00 (+0.46%) |
Nasdaq FuturesNQ=F | 18,611.00+152.75 (+0.83%) |
30.33+0.56% | |
HANG SENG INDEX^HSI | 17,196.96-1.42% |
23.92+6.83% |